RECURRENT OR REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS

Clinical trials for RECURRENT OR REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS explained in plain language.

Never miss a new study

Get alerted when new RECURRENT OR REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS trials appear

Sign up with your email to follow new studies for RECURRENT OR REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

One-Shot treatment tested to reset immune system in severe autoimmune diseases

Disease control Recruiting now

This early-stage study is testing a new one-time treatment called V001-BCMA for people with severe autoimmune diseases that have not responded to standard therapies. The treatment uses a patient's own modified immune cells (CAR-T cells) to target and remove harmful B cells that d…

Matched conditions: RECURRENT OR REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS

Phase: EARLY_PHASE1 • Sponsor: Tongji Hospital • Aim: Disease control

Last updated Mar 30, 2026 14:33 UTC

RECURRENT OR REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS

Get alerted when new RECURRENT OR REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS trials appear

One-Shot treatment tested to reset immune system in severe autoimmune diseases